FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020512200> ?p ?o ?g. }

• W2020512200 endingPage "e114111" @default.
• W2020512200 startingPage "e114111" @default.
• W2020512200 abstract "Best long-term practice in primary HIV-1 infection (PHI) remains unknown for the individual. A risk-based scoring system associated with surrogate markers of HIV-1 disease progression could be helpful to stratify patients with PHI at highest risk for HIV-1 disease progression.We prospectively enrolled 290 individuals with well-documented PHI in the Zurich Primary HIV-1 Infection Study, an open-label, non-randomized, observational, single-center study. Patients could choose to undergo early antiretroviral treatment (eART) and stop it after one year of undetectable viremia, to go on with treatment indefinitely, or to defer treatment. For each patient we calculated an a priori defined Acute Retroviral Syndrome Severity Score (ARSSS), consisting of clinical and basic laboratory variables, ranging from zero to ten points. We used linear regression models to assess the association between ARSSS and log baseline viral load (VL), baseline CD4+ cell count, and log viral setpoint (sVL) (i.e. VL measured ≥90 days after infection or treatment interruption).Mean ARSSS was 2.89. CD4+ cell count at baseline was negatively correlated with ARSSS (p = 0.03, n = 289), whereas HIV-RNA levels at baseline showed a strong positive correlation with ARSSS (p<0.001, n = 290). In the regression models, a 1-point increase in the score corresponded to a 0.10 log increase in baseline VL and a CD4+ cell count decline of 12/µl, respectively. In patients with PHI and not undergoing eART, higher ARSSS were significantly associated with higher sVL (p = 0.029, n = 64). In contrast, in patients undergoing eART with subsequent structured treatment interruption, no correlation was found between sVL and ARSSS (p = 0.28, n = 40).The ARSSS is a simple clinical score that correlates with the best-validated surrogate markers of HIV-1 disease progression. In regions where ART is not universally available and eART is not standard this score may help identifying patients who will profit the most from early antiretroviral therapy." @default.
• W2020512200 created "2016-06-24" @default.
• W2020512200 creator A5004628986 @default.
• W2020512200 creator A5007835940 @default.
• W2020512200 creator A5013001358 @default.
• W2020512200 creator A5033010131 @default.
• W2020512200 creator A5060727664 @default.
• W2020512200 creator A5066667348 @default.
• W2020512200 creator A5069244385 @default.
• W2020512200 creator A5086552318 @default.
• W2020512200 creator A5089009771 @default.
• W2020512200 date "2014-12-09" @default.
• W2020512200 modified "2023-10-16" @default.
• W2020512200 title "A Novel Acute Retroviral Syndrome Severity Score Predicts the Key Surrogate Markers for HIV-1 Disease Progression" @default.
• W2020512200 cites W145705621 @default.
• W2020512200 cites W1747388392 @default.
• W2020512200 cites W188952702 @default.
• W2020512200 cites W1972248422 @default.
• W2020512200 cites W1973741816 @default.
• W2020512200 cites W197449497 @default.
• W2020512200 cites W1977209539 @default.
• W2020512200 cites W1978406880 @default.
• W2020512200 cites W1983279331 @default.
• W2020512200 cites W1993655001 @default.
• W2020512200 cites W1997500258 @default.
• W2020512200 cites W2000911003 @default.
• W2020512200 cites W2003416089 @default.
• W2020512200 cites W2005006791 @default.
• W2020512200 cites W2008972159 @default.
• W2020512200 cites W2009573893 @default.
• W2020512200 cites W2010722833 @default.
• W2020512200 cites W2012139740 @default.
• W2020512200 cites W2022762562 @default.
• W2020512200 cites W2026814484 @default.
• W2020512200 cites W2031754540 @default.
• W2020512200 cites W2038176794 @default.
• W2020512200 cites W2040310825 @default.
• W2020512200 cites W2042815830 @default.
• W2020512200 cites W2053363350 @default.
• W2020512200 cites W2059761504 @default.
• W2020512200 cites W2067914298 @default.
• W2020512200 cites W2086085111 @default.
• W2020512200 cites W2098951833 @default.
• W2020512200 cites W2101802027 @default.
• W2020512200 cites W2106336618 @default.
• W2020512200 cites W2112182958 @default.
• W2020512200 cites W2113780394 @default.
• W2020512200 cites W2117775197 @default.
• W2020512200 cites W2121256913 @default.
• W2020512200 cites W2121892114 @default.
• W2020512200 cites W2122280827 @default.
• W2020512200 cites W2123584222 @default.
• W2020512200 cites W2125143013 @default.
• W2020512200 cites W2126141460 @default.
• W2020512200 cites W2139217795 @default.
• W2020512200 cites W2148391396 @default.
• W2020512200 cites W2148750104 @default.
• W2020512200 cites W2151587318 @default.
• W2020512200 cites W2153787696 @default.
• W2020512200 cites W2157752701 @default.
• W2020512200 cites W2158562439 @default.
• W2020512200 cites W2158564605 @default.
• W2020512200 cites W2163036286 @default.
• W2020512200 cites W2168776079 @default.
• W2020512200 cites W2171141994 @default.
• W2020512200 cites W2171149970 @default.
• W2020512200 cites W2182777591 @default.
• W2020512200 cites W2314461521 @default.
• W2020512200 cites W2929867264 @default.
• W2020512200 cites W4240153861 @default.
• W2020512200 doi "https://doi.org/10.1371/journal.pone.0114111" @default.
• W2020512200 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4260784" @default.
• W2020512200 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25490090" @default.
• W2020512200 hasPublicationYear "2014" @default.
• W2020512200 type Work @default.
• W2020512200 sameAs 2020512200 @default.
• W2020512200 citedByCount "15" @default.
• W2020512200 countsByYear W20205122002015 @default.
• W2020512200 countsByYear W20205122002017 @default.
• W2020512200 countsByYear W20205122002018 @default.
• W2020512200 countsByYear W20205122002019 @default.
• W2020512200 countsByYear W20205122002020 @default.
• W2020512200 countsByYear W20205122002021 @default.
• W2020512200 countsByYear W20205122002022 @default.
• W2020512200 crossrefType "journal-article" @default.
• W2020512200 hasAuthorship W2020512200A5004628986 @default.
• W2020512200 hasAuthorship W2020512200A5007835940 @default.
• W2020512200 hasAuthorship W2020512200A5013001358 @default.
• W2020512200 hasAuthorship W2020512200A5033010131 @default.
• W2020512200 hasAuthorship W2020512200A5060727664 @default.
• W2020512200 hasAuthorship W2020512200A5066667348 @default.
• W2020512200 hasAuthorship W2020512200A5069244385 @default.
• W2020512200 hasAuthorship W2020512200A5086552318 @default.
• W2020512200 hasAuthorship W2020512200A5089009771 @default.
• W2020512200 hasBestOaLocation W20205122001 @default.
• W2020512200 hasConcept C126322002 @default.
• W2020512200 hasConcept C141341695 @default.
• W2020512200 hasConcept C142462285 @default.

• next